Evidence map›Paper›PMID 33421550›Full record

ArticleToxicology letters2021

Glutathione is a potential therapeutic target for acrolein toxicity in the cornea.

Suneel Gupta, Sabeeh Kamil, Prashant R Sinha, Jason T Rodier, Shyam S Chaurasia, Rajiv R Mohan

Open access · greenAbstract read
In one paragraph

Article in Toxicology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Long-Term Tolerability and Safety of AAV5-Id3 Gene Therapy to Eyes.Translational vision science & technology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Suneel GuptaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Department of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.
Sabeeh KamilHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Department of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.
Prashant R SinhaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Department of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.
Jason T RodierHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, United States.
Shyam S ChaurasiaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Department of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.
Rajiv R MohanHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Department of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, United States. Electronic address: mohanr@health.missouri.edu.
Missouri College · USHarry S. Truman Memorial Veterans' Hospital · US

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur MustardU01EY031650 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2020 to 2024
$3.7M
Role of S100 proteins in Diabetic RetinopathyR01EY029795 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHAURASIA, SHYAM SUNDER · 2019 to 2023
$2.2M
Novel approaches for corneal haze/fibrosis eliminationR01EY030774 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2019 to 2022
$1.5M
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur MustardR21EY030234 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2018 to 2019
$426k
Nanomedicine Approach to Counteract Acrolien-induced Blindness and Toxicity to the EyeR21EY030233 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHAURASIA, SHYAM SUNDER, GIULIANO, ELIZABETH · 2018 to 2019
$425k
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal DiseasesI01BX000357 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Rajiv Ravindra Mohan · 2009 to 2026
–
BLR&D Research Career Scientist Award Application (Renewal)IK6BX005646 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI MOHAN, RAJIV RAVINDRA · 2021 to 2025
–
BLRD VA I01 BX000357BLRD VA IK6 BX005646NEI NIH HHS R01 EY017294NEI NIH HHS R01 EY029795NEI NIH HHS R01 EY030774NEI NIH HHS R21 EY030233NEI NIH HHS R21 EY030234NEI NIH HHS U01 EY031650
6 · The paper itself

Abstract

Toxic and volatile chemicals are widely used in household products and previously used as warfare agents, causing a public health threat worldwide. This study aimed to evaluate the extent of injury and mechanisms of acrolein toxicity in the cornea. Primary human corneal stromal fibroblasts cultures (hCSFs) from human donor cornea were cultured and exposed to acrolein toxicity with -/+ N-acetylcysteine (NAC) to study the mode of action in the presence of Buthionine sulphoximine (BSO). PrestoBlue and MTT assays were used to optimize acrolein, NAC, and BSO doses for hCSFs. Cell-based assays and qRT-PCR analyses were performed to understand the acrolein toxicity and mechanisms. Acrolein exposure leads to an increased reactive oxygen species (ROS), compromised glutathione (GSH) levels, and mitochondrial dysfunction. The TUNEL and caspase assays showed that acrolein caused cell death in hCSFs. These deleterious effects can be mitigated using NAC in hCSFs, suggesting that GSH can be a potential target for acrolein toxicity in the cornea.

Indexed as

AcroleinCaspase 3Caspase 7Cells, CulturedCell SurvivalCorneaCytoprotectionFibroblastsGene Expression RegulationGlutathioneHumansLipid PeroxidationLipidsMembrane Potential, MitochondrialOxidative StressReactive Oxygen SpeciesAcroleinCaspase 3Caspase 7GlutathioneLipidsReactive Oxygen SpeciesAcroleinGlutathione (GSH)Human corneal fibroblasts (hCSFs)Lipid peroxide (LPO)N-acetyl cysteine (NAC)Reactive oxygen species (ROS)

Identifiers

PMID33421550
PMCPMC9206442
OpenAlexW3119481460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.